MedPath
NMPA Approval

Peramivir Injection

国药准字H20249584

December 1, 2024

Drug Information

帕拉米韦注射液

注射剂

15ml:0.15g(按C₁₅H₂₈N₄O₄计)

化学药品

December 1, 2024

Company Information

Applicant Company

山西省大同经济技术开发区医药工业园区二园区通源街909号

Manufacturing Company

山西省大同市阳高西北街6号

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

帕拉米韦注射液 - NMPA 批准文号 | MedPath